EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria ... seizures, angina, dyspnea, or thrombosis. In addition ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Samsung Bioepis announced the availability of EPYSQLI (eculizumab-aagh) in the U.S. EPYSQLI is a biosimilar to Soliris ...

All had exertional dyspnea for a period varying from six years to one month prior to entry to the hospital, and all had suffered one or more episodes of paroxysmal nocturnal dyspnea. Moderate to ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease that develops when your blood cells are formed. It can lead to the abnormal destruction of blood cells, resulting in various symptoms.

Interwoven with these night-time expeditions is the film’s fourth layer: a theatrical adaptation inspired by Djuna Barnes’ “Nightwood,” a novel steeped in nocturnal imagery. Actors will ...

Heart failure can cause insufficient sleep due to symptoms such a paroxysmal nocturnal dyspnoea and/or Cheyne Stoke Respiration, use of medications that can cause sleep disruptions (e.g., diuretics) ...

Even though paroxysmal nocturnal hemoglobinuria (PNH) is rare, there are effective treatments—some of which can potentially cure the condition. However, the treatments have risks that people with the ...